MBX Biosciences, Inc. MBX
$41.03
▼ -4.67% 24H
About
Mbx Biosciences Inc. is a biopharmaceutical company focused on the research and development of innovative endocrine therapeutics. It strives to address unmet medical needs through pioneering treatments for endocrine disorders. The company's central aim is to develop precision endocrinology therapies, leveraging proprie…
SectorHealthcare
ExchangeNASDAQ
IndustryBiotechnology
CountryUnited States
Employees63
TickerMBX
Statistics
Market Cap$1.95B
Revenue (TTM)—
Net Income-$87.0M
Net Margin—
EPS$-2.38
P/E3.74
P/S—
P/B3.30
EV/EBITDA-9.97
ROE-25.7%
Dividend Yield—
Price$41.03
Data: Twelve Data · Revenue = mcap / P/S